At a House Oversight Committee hearing on Tuesday, executives from three major pharmacy benefit managers (PBMs) pushed back against bipartisan criticism from lawmakers who blame the industry for high drug prices. The executives said PBMs save patients money, and that customers actively choose to work with PBMs to get those savings, and blamed drug companies for the high prices. Without a PBM to negotiate with,…